Regulatory
The Northern Irish pharmacy regulator has revealed proposals for a fee rise, having made a pre-tax loss of almost £200,000.
The medicines watchdog has received reports of some 10 deaths “with glucagon-like peptide-1 receptor agonists (GLP-1RAs) indicated for weight management” such as Wegovy and Mounjaro, C+D can reveal.
The Care Quality Commission (CQC) is set to fill the “legal loophole” that currently leaves pharmacist-owned-businesses that are run from unregistered premises completely unregulated, the pharmacy regulator has said.